Treatment of latent infection with Mycobacterium tuberculosis: update 2010 Source: Eur Respir J 2011; 37: 690-711 Year: 2011
Bone and joint tuberculosis in Bradford: a 6 year review (1999-2004) Source: Annual Congress 2005 - Management of tuberculosis pulmonary, extrapulmonary peculiarities Year: 2005
Treatment outcomes in patients with multidrug-resistant tuberculosis in Japan, 2011-2013 Source: International Congress 2017 – MDRTB: detection and management Year: 2017
High proportion of fluoroquinolone mono-resistant mycobacterium tuberculosis (MTB) strains in Pakistan (2010-2012) Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Progress of treatment delayed testicular tuberculosis: One case Source: Annual Congress 2013 –Tuberculosis: clinical aspects Year: 2013
WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011
Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004 Source: Eur Respir J 2010; 36: 584-593 Year: 2010
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement}, Source: Eur Respir J 2012; 40: 990-1013 Year: 2012
The trend of tuberculosis in Bucharest between years 2001 – 2013 Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1 Year: 2014
Analysis of TB denotifications in North London (2003 – 2012) Source: Annual Congress 2013 –Epidemiological and public health features of tuberculosis Year: 2013
The top of the iceberg - Extensively drug resistant tuberculosis (XDR-TB) in 2010 Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children Year: 2015
Rapid monitoring of tuberculosis treatment response: A multi-centre study Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment Year: 2016
Drug resistance pattern of mycobacterium tuberculosis complex at the main reference tuberculosis centre in Greece, 2000-2010 Source: Annual Congress 2011 - Epidemiology of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2011
Characteristics of patients under treatment for NTM disease during the period 2004-2013 in Greece Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 2 Year: 2014
Four cases, one family: A cluster of resistant tuberculosis Source: Annual Congress 2013 –Drug-resistant tuberculosis Year: 2013
Two case reports: The successful management of pulmonary mycobacterium bohemicum Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA) Year: 2016
Lymphocytopenia in pulmonary tuberculosis: Does it have a clinical value? Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Liver injury in treatment of latent tuberculosis infection - is the age cut-off for treatment justified? Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches Year: 2014
Experience of skin test application using tuberculosis recombinant allergen (Diaskintest) in tuberculosis diagnostics of children Source: International Congress 2015 – Biomarkers in TB: immunology and physiology Year: 2015
Acceptance, and compliance to treatment for latent tuberculous infection (LTBI) in Geneva (1993-2002) Source: Eur Respir J 2005; 26: Suppl. 49, 645s Year: 2005